Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Leflon

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
La Revue De Medecine Interne|May 17, 2005
[Aetiological spectrum of hyperferritinemia]L Le Page, P Leflon, M Mahévas, et al.
Bone|January 1, 1985
Assessment of the aluminum overload and of its possible toxicity in asymptomatic uremic patients: evidence for a depressive effect on bone formationJ L Sebert, A Marie, J Gueris, et al.
Nephrologie|January 1, 1988
[Indirect evaluation of the effect of 1 alpha-hydroxyvitamin D3 on intestinal absorption of aluminum]R Demontis, D Reissi, C Noël, et al.
Clinical Nephrology|March 1, 1989
Indirect clinical evidence that 1 alpha OH vitamin D3 increases the intestinal absorption of aluminumR Demontis, D Reissi, C Noel, et al.
Journal of Photochemistry and Photobiology. B, Biology|March 30, 2000
Contrasting effects of excess ferritin expression on the iron-mediated oxidative stress induced by tert-butyl hydroperoxide or ultraviolet-A in human fibroblasts and keratinocytesA Giordani, J Haigle, P Leflon, et al.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
Influence of biochemical and hormonal factors on the bone histomorphometric features of uraemic patientsA Fournier, J L Sebert, P Fohrer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1988
Magnesium hydroxide as a complementary aluminium-free phosphate binder to moderate doses of oral calcium in uraemic patients on chronic haemodialysis: lack of deleterious effect on bone mineralisationP Morinière, I Vinatier, P F Westeel, et al.
Kidney International. Supplement|February 1, 1986
Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremiaA Fournier, P Moriniere, J L Sebert, et al.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
The desferrioxamine test predicts bone aluminium burden induced by A1(OH)3 in uraemic patients but not mild histological osteomalaciaA Fournier, P Fohrer, P Leflon, et al.
Contributions to Nephrology|January 1, 1988
Calcium carbonate and magnesium hydroxide in the prevention of renal osteodystrophy or the demise of aluminum toxicity in uremia. Analysis of 5 years experienceP Morinière, A Fournier, P F Westeel, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
La Revue De Medecine Interne|May 17, 2005
[Aetiological spectrum of hyperferritinemia]L Le Page, P Leflon, M Mahévas, et al.
Bone|January 1, 1985
Assessment of the aluminum overload and of its possible toxicity in asymptomatic uremic patients: evidence for a depressive effect on bone formationJ L Sebert, A Marie, J Gueris, et al.
Nephrologie|January 1, 1988
[Indirect evaluation of the effect of 1 alpha-hydroxyvitamin D3 on intestinal absorption of aluminum]R Demontis, D Reissi, C Noël, et al.
Clinical Nephrology|March 1, 1989
Indirect clinical evidence that 1 alpha OH vitamin D3 increases the intestinal absorption of aluminumR Demontis, D Reissi, C Noel, et al.
Journal of Photochemistry and Photobiology. B, Biology|March 30, 2000
Contrasting effects of excess ferritin expression on the iron-mediated oxidative stress induced by tert-butyl hydroperoxide or ultraviolet-A in human fibroblasts and keratinocytesA Giordani, J Haigle, P Leflon, et al.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
Influence of biochemical and hormonal factors on the bone histomorphometric features of uraemic patientsA Fournier, J L Sebert, P Fohrer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1988
Magnesium hydroxide as a complementary aluminium-free phosphate binder to moderate doses of oral calcium in uraemic patients on chronic haemodialysis: lack of deleterious effect on bone mineralisationP Morinière, I Vinatier, P F Westeel, et al.
Kidney International. Supplement|February 1, 1986
Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremiaA Fournier, P Moriniere, J L Sebert, et al.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
The desferrioxamine test predicts bone aluminium burden induced by A1(OH)3 in uraemic patients but not mild histological osteomalaciaA Fournier, P Fohrer, P Leflon, et al.
Contributions to Nephrology|January 1, 1988
Calcium carbonate and magnesium hydroxide in the prevention of renal osteodystrophy or the demise of aluminum toxicity in uremia. Analysis of 5 years experienceP Morinière, A Fournier, P F Westeel, et al.
Pageof 3